| Product NDC: | 0029-1526 |
| Proprietary Name: | BACTROBAN |
| Non Proprietary Name: | mupirocin calcium |
| Active Ingredient(s): | 20 mg/g & nbsp; mupirocin calcium |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0029-1526 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050703 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960410 |
| Package NDC: | 0029-1526-11 |
| Package Description: | 10 CARTON in 1 PACKAGE (0029-1526-11) > 1 TUBE in 1 CARTON (0029-1526-03) > 1 g in 1 TUBE |
| NDC Code | 0029-1526-11 |
| Proprietary Name | BACTROBAN |
| Package Description | 10 CARTON in 1 PACKAGE (0029-1526-11) > 1 TUBE in 1 CARTON (0029-1526-03) > 1 g in 1 TUBE |
| Product NDC | 0029-1526 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mupirocin calcium |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 19960410 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | MUPIROCIN CALCIUM |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |